Clinical and Life Sciences · 30 September 2026 to 30 September 2026 · 1 headlines · MedPage Today
Safe and Effective Therapies for Unfit Elderly Patients With DLBCL
New reporting addresses treatment options for elderly patients with diffuse large B-cell lymphoma (DLBCL) who are considered medically unfit for standard intensive therapy, highlighting approaches described as both safe and effective for this population.
As it ran
30 September 2026
More from US healthcare
- Senate Committee Advances Surgeon General Nominee 30 September 2026
- Trump health policies' rural reach gap 30 September 2026
- America’s biotech race with China must be won at home 30 September 2026
- CAR-T Therapy Shows Durable Benefits in Myasthenia Gravis 30 September 2026
- Deals tracker: Sharp Healthcare partners with DISC Surgery Center 30 September 2026
- Drugs Are Widely Used To Sedate Dementia Patients. Her Sons Wanted To Keep Her Off Them. 30 September 2026
- “Here to Stay”: 3 Providers on The Future of AI in ABA Therapy 30 September 2026
- HOPDs' higher drug payment rates drive $12.7B in spending: EBRI 30 September 2026